Bhuyan PK - Search Results

1

Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population.

Hollenberg RK, Krieger DR, Samuels R, Kraynyak K, Sylvester A, Morrow M, Boyer J, Dallas M, Bhuyan PK. Hollenberg RK, et al. Among authors: bhuyan pk. Hum Vaccin Immunother. 2020 Jun 2;16(6):1404-1412. doi: 10.1080/21645515.2019.1695459. Epub 2019 Dec 20. Hum Vaccin Immunother. 2020. PMID: 31860383 Free PMC article. Clinical Trial.

2

Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL.

Bhuyan PK, Dallas M, Kraynyak K, Herring T, Morrow M, Boyer J, Duff S, Kim J, Weiner DB. Bhuyan PK, et al. Hum Vaccin Immunother. 2021 May 4;17(5):1288-1293. doi: 10.1080/21645515.2020.1823778. Epub 2020 Nov 11. Hum Vaccin Immunother. 2021. PMID: 33175656 Free PMC article. Clinical Trial.

3

Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adults.

Van Damme P, Minervini G, Liss CL, McCarson B, Vesikari T, Boslego JW, Bhuyan PK. Van Damme P, et al. Among authors: bhuyan pk. Hum Vaccin. 2009 Feb;5(2):92-7. doi: 10.4161/hv.5.2.6587. Epub 2009 Feb 14. Hum Vaccin. 2009. PMID: 18690015 Clinical Trial.

4

Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.

Gilbert CL, Klopfer SO, Martin JC, Schödel FP, Bhuyan PK. Gilbert CL, et al. Among authors: bhuyan pk. Hum Vaccin. 2011 Dec;7(12):1336-42. doi: 10.4161/hv.7.12.18333. Epub 2011 Dec 1. Hum Vaccin. 2011. PMID: 22185811 Clinical Trial.

5

Immunogenicity, safety, and tolerability of the meningococcal serogroup B bivalent rLP2086 vaccine in adult laboratory workers.

Reiner DM, Bhuyan P, Eiden JJ, Ginis J, Harris S, Jansen KU, Jiang Q, Jones TR, O'Neill RE, York LJ, Perez JL. Reiner DM, et al. Vaccine. 2016 Feb 3;34(6):809-13. doi: 10.1016/j.vaccine.2015.12.016. Epub 2015 Dec 19. Vaccine. 2016. PMID: 26707218 Clinical Trial.

6

Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine.

Senders S, Bhuyan P, Jiang Q, Absalon J, Eiden JJ, Jones TR, York LJ, Jansen KU, O'Neill RE, Harris SL, Ginis J, Perez JL. Senders S, et al. Pediatr Infect Dis J. 2016 May;35(5):548-54. doi: 10.1097/INF.0000000000001072. Pediatr Infect Dis J. 2016. PMID: 26835974 Clinical Trial.

7

Safety and immunogenicity of a modified process hepatitis B vaccine in healthy infants.

Vesikari T, Martin JC, Liss CL, Liska V, Schödel FP, Bhuyan PK. Vesikari T, et al. Among authors: bhuyan pk. Pediatr Infect Dis J. 2011 Jul;30(7):e109-13. doi: 10.1097/INF.0b013e31821ed1a4. Pediatr Infect Dis J. 2011. PMID: 21552183 Clinical Trial.

8

Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age.

Halperin SA, Tapiero B, Diaz-Mitoma F, Law BJ, Hoffenbach A, Zappacosta PS, Radley D, McCarson BJ, Martin JC, Brackett LE, Boslego JW, Hesley TM, Bhuyan PK, Silber JL. Halperin SA, et al. Among authors: bhuyan pk. Vaccine. 2009 Apr 28;27(19):2540-7. doi: 10.1016/j.vaccine.2008.11.115. Epub 2009 Jan 3. Vaccine. 2009. PMID: 19124057 Clinical Trial.

9

Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 4, 6 and 12-14 months of age.

Diaz-Mitoma F, Halperin SA, Tapiero B, Hoffenbach A, Zappacosta PS, Radley D, Bradshaw S, Martin JC, Boslego JW, Hesley TM, Bhuyan PK, Silber JL. Diaz-Mitoma F, et al. Among authors: bhuyan pk. Vaccine. 2011 Feb 1;29(6):1324-31. doi: 10.1016/j.vaccine.2010.11.053. Epub 2010 Dec 4. Vaccine. 2011. PMID: 21134456 Clinical Trial.

10

Immunogenicity and safety of a Haemophilus influenzae B (Hib)-hepatitis B vaccine with a modified process hepatitis B component administered with concomitant pneumococcal conjugate vaccine to infants.

Lee AW, Vesikari T, Gilbert CL, Klopfer SO, Schödel FP, Bhuyan PK. Lee AW, et al. Among authors: bhuyan pk. Vaccine. 2011 Oct 19;29(45):7942-8. doi: 10.1016/j.vaccine.2011.08.071. Epub 2011 Aug 27. Vaccine. 2011. PMID: 21875633 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page